Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Trazodone HCl (New Polymer) vs Contramid in Healthy Volunteers
NCT06773767Phase 1Completed
- Sponsor
- Angelini Pharma
- Start
- May 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of trazodone in major depressive disorder (MDD) (2 arms), sponsored by Angelini Pharma. Primary endpoint: Assessment of bioequivalence of trazodone hydrochloride tablets at 5 days. Started May 2024; status: completed.
02
Drugs
trazodone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06773767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06773767.